Pre-treatment with curcumin, a component of the spice turmeric, makes ovarian cancer cells more vulnerable to chemotherapy and radiotherapy. Researchers writing in BioMed Central's open access Journal of Ovarian Research found that delivering the curcumin via very small (less than 100nm) nanoparticles enhanced the sensitizing effect. Subhash Chauhan, PhD, and Meena Jaggi, PhD, led a team of researchers from Sanford Research and the University of South Dakota, USA, who carried out the in vitro study...
More...
More...